(3aS,8aR)-2-(Isoquinolin-3-yl)-3a,8a-dihydro-8H-indeno[1,2-d]oxazole
97%
- Product Code: 236853
CAS:
2321534-63-6
Molecular Weight: | 286.33 g./mol | Molecular Formula: | C₁₉H₁₄N₂O |
---|---|---|---|
EC Number: | MDL Number: | ||
Melting Point: | Boiling Point: | ||
Density: | Storage Condition: | 2-8°C, Inert Gas |
Product Description:
Used in pharmaceutical research as a key intermediate for synthesizing bioactive compounds targeting neurological disorders. Shows potential in the development of dopamine receptor modulators, particularly for treating Parkinson’s disease and schizophrenia. Its rigid polycyclic structure enhances binding selectivity, improving drug efficacy and reducing off-target effects. Also explored in positron emission tomography (PET) tracer design due to favorable brain penetration and metabolic stability.
Sizes / Availability / Pricing:
Size | Availability | Price | Quantity |
---|---|---|---|
0.100 | 10-20 days | Ft49,073.63 |
+
-
|
0.250 | 10-20 days | Ft84,486.50 |
+
-
|
1.000 | 10-20 days | Ft293,285.84 |
+
-
|
(3aS,8aR)-2-(Isoquinolin-3-yl)-3a,8a-dihydro-8H-indeno[1,2-d]oxazole
Used in pharmaceutical research as a key intermediate for synthesizing bioactive compounds targeting neurological disorders. Shows potential in the development of dopamine receptor modulators, particularly for treating Parkinson’s disease and schizophrenia. Its rigid polycyclic structure enhances binding selectivity, improving drug efficacy and reducing off-target effects. Also explored in positron emission tomography (PET) tracer design due to favorable brain penetration and metabolic stability.
Mechanism | - |
Appearance | - |
Longevity | - |
Strength | - |
Storage | - |
Shelf Life | - |
Allergen(s) | - |
Dosage (Range) | - |
Recommended Dosage | - |
Dosage (Per Day) | - |
Recommended Dosage (Per Day) | - |
Mix Method | - |
Heat Resistance | - |
Stable in pH range | - |
Solubility | - |
Product Types | - |
INCI | - |
Purchase History for
Loading purchase history...
Cart
No products
Subtotal:
Ft0.00
Ft0.00
Total :